A clinical Study on Bronchial Asthma in childre
- Conditions
- Health Condition 1: null- Diseased having signs and symptoms of bronchial asthma
- Registration Number
- CTRI/2015/11/006340
- Lead Sponsor
- DIRECTOR
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 40
Patients of 2 to 12 years of age of either sex
Diagnosed cases of Tamaka Shwasa Bronchial Asthma with at least 2 episodes of asthma symptoms during the previous year
Patients on other drug therapy will be included only after completion of wash out period of 3 weeks
Patients or Parents or legal guardians willing to give written informed consent or assent
Children of age below 2 years and above the 12 years
Evidence of active concomitants pulmonary disease other than asthma
Evidence of requirement of intubations for asthma or had been hospitalized for asthma within one month before. Had unresolved sinus disease or an unresolved upper or lower respiratory tract infection within 2 weeks
Patients on active corticosteroid therapy or more than 4 short courses of oral corticosteroids within the year preceding the screening visit or any oral corticosteroids in the preceding 4 weeks
Use of Astemizole Nedocromil Cromolyn long acting beta agonists Ketotifen or Theophylline within 2 weeks before
Concomitant severe decompensated systemic disease cardiovascular renal hepatic endocrine hematological neurological immunological
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relieve in the sign and symptom of Shwasa Roga or Bronchial asthmaTimepoint: 8 weeks
- Secondary Outcome Measures
Name Time Method To prevent the recurrence of attacks of breathlessness <br/ ><br>To increase the immunity against allergensTimepoint: 8 weeks